Clin2
NCT06201858Likely a fitNot yet recruiting

HS Patient Participation Patterns Study

Hidradenitis Suppurativa

Part of Infections, Skin clinical trials.

This study explores how people with hidradenitis suppurativa (HS) participate in research. You'll report your health regularly using a device, and the goal is to better understand patient experiences.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
500 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are 18 years old or older.
  • You have been diagnosed with hidradenitis suppurativa (HS).
  • You are not pregnant or nursing.
  • You can use a smartphone, computer, or tablet to report your health regularly.
  • You do not have a psychiatric condition or substance abuse issue that would make it hard to follow the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04115566Recruiting
HS patient registry and sample storage study

This study enrolls people with hidradenitis suppurativa (HS) to better understand the condition over time and store optional health information and samples. Being in the registry may help researchers learn about patterns in HS and support future research.

San Francisco, California
NCT03967600Recruiting
Study of hidradenitis suppurativa skin features

This study looks at the physical and biological (body-related) characteristics of hidradenitis suppurativa. It may help researchers understand the condition better and improve future care.

San Francisco, California
NCT06895499Recruiting· Phase 1/Phase 2
Testing a new drug for hidradenitis suppurativa

This trial tests a new medicine called HB0043 for people with moderate to severe hidradenitis suppurativa (a skin condition causing painful lumps). It aims to see if the drug is safe and helps reduce symptoms.

Jinan, Shandong
NCT07543419Recruiting
Real-world Study of Secukinumab for Moderate to Severe Hidradenitis Suppurativa

This study tracks how secukinumab (a new medication) works for hidradenitis suppurativa—a painful skin condition with recurring boils and abscesses—in real-world patient care in Italy. Researchers want to understand treatment patterns and outcomes to help improve care for this condition.

Ancona, AN
NCT05208099Not yet recruiting
Study treatment targeting the immune system for hidradenitis

This trial tests an immune-focused treatment strategy for adults with moderate-to-severe hidradenitis suppurativa (HS), especially for cases where surgery is needed. If eligible, you may get a planned study treatment and be compared to a group without HS undergoing a related surgery.

Lille
NCT06324552Recruiting
Skin cell function in HS patients

This study looks at how skin cells work in people with hidradenitis suppurativa (HS), a condition that causes painful lumps under the skin. It aims to understand the disease better, which might lead to improved treatments in the future.

Innsbruck

Hear when a new Hidradenitis Suppurativa trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.